Top 10 Biotechnology Startup Investors in Latvia in October 2023
Top 10 Biotechnology Startup Investors in Latvia in October 2023
| Investor | Biotechnology Latvia investments |
|---|---|
| Abingworth | 2 |
| FlyCap | 2 |
| Qiming Venture Partners USA | 2 |
| TSVC | 1 |
| ZGI Capital | 1 |
| Roche Venture Fund | 1 |
| Citadel | 1 |
| Surveyor Capital | 1 |
| Imprimatur Capital Fund Management | 1 |
| Alexandria Venture Investments | 1 |
Get 300+ niche investors in 2 minutes.
Find who invests in your industry, stage, and region in our 200k+ database with AI-powered matching.
Find investors — It's Free!Trusted by 21,000+ founders from:
We are Abingworth, a trans-atlantic bio-science investment firm with a deep understanding of both the science and markets we invest in.
Show more...Investment focus
- Biotechnology, Health Care, Pharmaceutical
- Series B, Series A, Series C
- United States, United Kingdom, Switzerland
Portfolio highlights
- Iambic Therapeutics — Iambic has created a cutting-edge AI-driven platform to tackle the most challenging design problems in drug discovery and address unmet patient need.
- Ascend Gene & Cell Therapies — Ascend Gene & Cell Therapies supports manufacturing and process development projects from design through to clinical and commercial scales. They partner with biotechnology teams to embed scalable manufacturing in their operations from the beginning. They respond to customer inquiries by phone and contact form.
- Spruce Biosciences — Developing and commercializing novel therapies for rare endocrine disorders with significant unmet medical need
FlyCap AIF is a Venture Capital Fund of total size of 15.75 MEUR. The Fund provides growth capital for Latvia based SME’s in a form of investments in equity and mezzanine capital.
Show more...Investment focus
- Health Care, Consumer Goods, Medical
- Funding Round, Seed, Debt Financing
- Latvia, Estonia, The Netherlands
Portfolio highlights
- Tapcore — Tapcore is the only solution on the market that enables mobile developers to monetize pirated copies of their apps through advertising. Established in 2015, we are a remote company with headquarters in the Netherlands. Currently we serve over 150 million ad requests daily (and counting!).
- Purified — Purified is a nutritional supplement supplier.. It offers black chocolate produced by the best doctors in collaboration with scientists.
- Elmo — In our car sharing business Elmo Rent we wanted to serve maximum customers with minimum resources, so we created remote control technology to deliver vehicles.
Qiming Venture Partners invests in young, fast-growing companies across China in the media and internet, IT, consumer and retail, healthcare, and clean technology sectors. we are early to growth stage venture capital firm with offices in Shanghai, Beijing and Hong Kong. Since their debut in 2006, we have established their selves as a leadinginvestment firm in China and currently manage four funds with over $1 billion in assets.
Show more...Investment focus
- Biotechnology, Health Care, Pharmaceutical
- Series A, Series B, Seed
- United States, China, Latvia
Portfolio highlights
- Entact Bio — Entact Bio is a biotechnology company that is in the preclinical stages of developing medications to improve protein function. It was founded by a team with deep roots in deubiquitinase (DUB) biochemistry, chemical biology, disease biology, and small-molecule drug development. The company's proprietary EncompassTM platform was designed tocreate enhancement-targeting chimeric (ENTACTM) medicines. ENTACs take advantage of DUBs' ability to regulate proteins.
- Soda Health — We are a healthcare technology company dedicated to eliminating health inequities through social determinants of health. Our services include supplemental benefit administration, highly customizable member benefit programs with restricted spending and multi-balance capabilities, and robust member data analytics with benefit design recommendations.
- Tenpoint Therapeutics — Tenpoint Therapeutics is a biotechnology company pursuing vision-restoring engineered cell-based therapeutics.
Founded in 2010, TSVC (formerly TEEC Angel Fund) is proud to be a leading early-stage venture capital fund in Silicon Valley.
Show more...Investment focus
- Software, Artificial Intelligence, Health Care
- Seed, Funding Round, Series A
- United States, China, Canada
Portfolio highlights
- Angle Health — Digital-First Health Plans For The Modern Employee
- KURUKURU — Bring your comics and visual stories to life in clicks on KURUKURU.
- Leadoptik — Leadoptik is a California-based company is currently operating in stealth mode.
ZGI Capital is the fund management company that manages "ZGI fund”, that was founded to support entrepreneurs lacking start-up capital for their business. The total amount of assets available for venture capital investments is of EUR 7.4M. Combined with bank financing, this will allow to finance investment projects with total assets of up toEUR 30M. The fund acts on behalf of various investors including the State.
Show more...Investment focus
- Manufacturing, Machinery Manufacturing, Consulting
- Funding Round, Seed, Debt Financing
- Latvia, Estonia
Portfolio highlights
- eAgronom — eAgronom helps farmers generate additional revenue streams, improve soil quality, and access better financing.
- KOOL Latvija — "KOOL Latvija" is a new concept gas station created in Latvia, which at the same time is also a convenient fast shopping place.
- Bioreactors.net — Biotechnical center is an innovative company and we provide solutions for industrial biotechnology processes, bioreactor manufacturing and industrial automation. We manufacture bioreactors for laboratory, pilot and industrial scale.
The Roche Venture Fund is the name given to the corporate venture fund of the healthcare company Roche. Roche has allocated CHF 500 million to invest in and develop commercially successful innovative life science companies. Roche has been investing in early stage companies as part of collaborations since the early-1990s and independent ofcollaborations since 2002. All equity investments made by Roche in biotech and diagnostics companies (including collaboration investments) are negotiated and managed by the Roche Venture Fund. In the past 20 years, the Roche Venture Fund has invested in over 60 companies globally. Currently, Roche Venture Fund has a portfolio of around 30 companies located in 10 countries across Europe, North America and the Pacific Region. The fund is an evergreen fund with CHF 500 million available of which approximately 40% is currently invested.The Roche Venture Fund is a committed long-term stable investor with sufficient money reserved in their fund for follow-on financing rounds. As part of a multinational healthcare company, the Roche Venture Fund has access to considerable expertise both internally and externally. We co-invest with leading venture funds, including other corporate venture funds, on a regular basis.
Show more...Investment focus
- Biotechnology, Health Care, Therapeutics
- Series B, Series A, Series C
- United States, United Kingdom, Spain
Portfolio highlights
- DiogenX — We incorporated DiogenX with the objective to provide new therapeutic solutions for diabetic patients. With Patrick Collombat and the team, we are focused on developing a first-in-class regenerative treatment for type 1 diabetes. Benjamin Charles CEO See the team News See more Our Work OUR APPROACH ABOUT DIABETES
- NMD Pharma — NMD Pharma is a small molecule drug discovery company that develops novel treatments of neuromuscular disorders.Research by the founders working on the neuromuscular junction identified an approach that has not previously been exploited but shows great promise.Importantly, the approach improves neuromuscular transmission in a way that ispotentially applicable to a range of clinical indications and orphan human diseases that have profound unmet medical need.
- Bonum Therapeutics — Bonum Therapeutics is focused on a proven technology that utilizes allosteric regulation to create targeted, highly active, and less toxic medicines.
We are an alternative investment manager working on behalf of the world's preeminent institutions. Discover our work, teams, careers and more.
Show more...Investment focus
- Biotechnology, Information Technology, Health Care
- Series A, Series C, Seed
- United States, India, Latvia
Portfolio highlights
- OYO — OYO Hotels in UK - Find the best last minute hotel deals with OYO hotels in UK. Book Budget hotels in London, Edinburgh, Manchester, Liverpool, Bristol with upto 50% off, Free cancellation, free WiFi & Breakfast.
- Quant — Quant is a premier quantitative research and investment fund led by engineering, mathematics, and business students at the University of Illinois Urbana-Champaign. We employ state-of-the-art analysis tools like deep learning and natural language processing to gain an edge on financial markets across the globe.
- Yellowbrick Data — Yellowbrick Data Warehouse: the only modern enterprise cloud data warehouse. Run complex queries on data dispersed across the enterprise, cloud, on-prem & edge.
Surveyor Capital is a fundamental equities business. Surveyor’s sector-aligned investment teams aim to generate alpha through a deep understanding of each company’s strategy, management teams, drivers of performance, and cyclical and secular industry trends over the medium and long term.
Show more...Investment focus
- Biotechnology, Health Care, Pharmaceutical
- Series B, Post-IPO Equity, Series C
- United States, Switzerland, China
Portfolio highlights
- Avalyn Pharma — This does NOT display on the home page
- Mariana Oncology — Mariana Oncology is a biotechnology research industry.
- VistaGen Therapeutics — VistaGen Therapeutics, Inc. is a clinical-stage biopharmaceutical company dedicated to developing and commercializing innovative product candidates for patients with diseases and disorders involving the central nervous system (CNS). VistaGen's lead product candidate, AV-101, is a next generation, orally available prodrug candidate in Phase 2development, initially for the adjunctive treatment of Major Depressive Disorder (MDD) in patients with an inadequate response to standard antidepressants.
Imprimatur Capital Fund Management is a venture capital firm focusing on high-technology at an early stage in its commercial development. We invest in start-up technology businesses which are based on innovative intellectual property, are led by strong teams and have high international growth potential.Imprimatur Capital Fund Management, based inLatvia, manages seed and start-up funds with investors including the Latvian Guarantee Agency, other institutional investors and some private investors. The company source investment opportunities primarily from the Baltic/Nordic/Russia region.Imprimatur Capital Fund Management is a partner firm of Imprimatur Capital Ltd, headquartered in London and with investment operations in Europe, Russia, Asia Pacific, Latin America and the US.
Show more...Investment focus
- Software, Music, Biotechnology
- Seed, Series A, Funding Round
- Latvia, Finland, United Kingdom
Portfolio highlights
- Edurio — Edurio is England's leading stakeholder feedback platform for schools and multi-academy trusts.
- Axial3D — Leading the way with the latest 3D imaging, models, and devices
- Sonarworks — SoundID Reference software calibrates your speakers and studio headphones, so you can trust that every mix will translate.
Alexandria Venture Investments is a venture capital firm that develops work in real estate technology, and healthcare sectors. The company's strategic venture capital platform is Alexandria Venture Investments. Since its inception in 1996, the company has invested in disruptive life science, agrifood tech, and technology companies that aredeveloping transformative new modalities and platforms to meaningfully improve human health.
Show more...Investment focus
- Biotechnology, Health Care, Therapeutics
- Series A, Series B, Series C
- United States, France, Canada
Portfolio highlights
- Deka Biosciences — Deka BioSciences, Inc. is committed to developing and delivering life-changing medicines to patients with cancer and inflammatory diseases.
- Solu Therapeutics — Solu Therapeutics is a precision-medicine-focused company developing therapeutics to eliminate disease-driving cells.
- Arialys Therapeutics — Arialys Therapeutics is a pre-clinical stage company that develops auto-antibody focusing on neuroscience. The company focuses on how the immune system impacts CNS health, disease, and treatment.
Close your round
Find who invests in your industry, stage, and region in our 200k+ database with AI-powered matching.
Find investors — It's Free!Join 21,000+ founders from: